Search Results
Oct 14, 2025, 08:00 ET Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from NMPA
- Novel cleavable linker: Ensures precise payload release in tumor tissues. - MF-6 payload: A proprietary DNA topoisomerase I inhibitor designed to overcome multidrug resistance (MDR), exhibiting superior plasma stability, controlled drug release, and potent
More news about: Mabwell
Oct 14, 2025, 07:30 ET Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
thicker plaques and lesions. This treatment approach avoids the risk of secondary malignancies (including melanoma) inherent with the frequently employed DNA-damaging drugs and other phototherapy that are dependent on ultraviolet exposure. Combined with photoactivation, hypericin has demonstrated significant
More news about: Soligenix
Oct 13, 2025, 12:10 ET Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
In both prostate and lung cancer, ATNM-400 leverages the potent, high-linear-energy-transfer emissions of Ac-225 to induce irreparable double-strand DNA breaks, a mechanism expected to overcome conventional resistance pathways and deliver durable tumor control. Sandesh
More news about: Actinium Pharmaceuticals, Inc.
Oct 13, 2025, 09:30 ET Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Oct 13, 2025, 08:30 ET Actinium to Present ATNM-400 Preclinical Data Highlighting Durable Tumor Control and Ability to Overcome Resistance to Standard-of-Care Prostate Cancer Therapies at the 32nd Annual Prostate Cancer Foundation Scientific Retreat
PSMA-resistant disease, a major unmet clinical need. Ac-225 delivers high-linear-energy-transfer alpha particles that induce irreparable double-strand DNA breaks, offering superior potency over beta emitters like Lutetium-177 (177Lu), and has a shorter tissue path length that may reduce off-target toxicity.
More news about: Actinium Pharmaceuticals, Inc.
Oct 13, 2025, 07:30 ET ADC Therapeutics Announces $60 Million Private Placement
internalized by the cell, where enzymes release a pyrrolobenzodiazepine (PBD) payload. The potent payload binds to DNA minor groove with little distortion, remaining less visible to DNA repair mechanisms. This ultimately results in cell cycle arrest and tumor cell death. The U.S.
More news about: ADC Therapeutics SA
Oct 13, 2025, 07:15 ET AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors
treatment in SCLC.4 In the same trial, ABBV-706 treatment also resulted in rapid clearance of circulating tumor DNA (ctDNA) and circulating tumor cells (CTC). Patients with 100% ctDNA clearance had significantly higher PFS and overall survival (OS) vs. patients without
More news about: AbbVie
Oct 13, 2025, 07:00 ET Results published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d)
incorporate the pyrimidine nucleosides, deoxycytidine and deoxythymidine, into skeletal muscle mitochondrial deoxyribonucleic acid (DNA). This action restores mitochondrial DNA copy number in TK2d mutant mice, as suggested by preclinical data.12,13,14 The safety and efficacy
More news about: UCB
Oct 13, 2025, 06:38 ET A Glimpse into the Future of "People, Cars and Life": The 2025 Chery International User Summit Set to Open
initiatives co-developed with UNICEF and the International Union for Conservation of Nature (IUCN)—embedding social responsibility into the brand's DNA; or through innovative technologies such as the AiMOGA Robotics and Argos robot dog, bringing "a trusted intelligent assistant for humanity" into everyday
More news about: Chery International
Oct 11, 2025, 11:45 ET LI-NING Welcomes Egor Dëmin to the Way of Wade Athlete Roster
as the "Prince of Gymnastics". Inspired by the legendary athletic career of its founder Mr. Li Ning, the brand carries an inherent athlete DNA. Its iconic slogan "Anything is Possible" has consistently shaped its journey. With a mission "Let Sports Light Your Passion", LI-NING
More news about: LI-NING
Oct 10, 2025, 19:32 ET KATE SPADE NEW YORK HOSTED FOURTH ANNUAL GLOBAL SUMMIT ON WOMEN'S MENTAL HEALTH WITH SPEAKERS TARA DAVIS-WOODHALL, ALYSON STONER, AMAYA ESPINAL, JOY WOODS AND MORE. THE SUMMIT SHINED LIGHT ON BRAND'S GLOBAL FUND FOR WOMEN'S MENTAL HEALTH GOAL TO REACH 250,000 WOMEN AND GIRLS WITH ACCESS TO COMMUNITY-CENTRIC MENTAL HEALTH SERVICES BY 2030
delivering seasonal collections of handbags, ready-to-wear, jewelry, footwear, gifts, home décor and more. Known for its rich heritage and unique brand DNA, Kate Spade New York offers a distinctive point of view and celebrates communities of women around the globe who live their perfectly imperfect lifestyles.
More news about: Kate Spade New York
Oct 10, 2025, 12:53 ET New Study Showed Unnecessary Burden From Continued Monitoring of Alloimmunized Pregnancies With Antigen-Negative Fetuses
s1. The study validates the clinical utility of fetal antigen cell-free DNA (cfDNA) testing and demonstrates how traditional antibody titer monitoring can lead to unnecessary monitoring and interventions in pregnancies that cfDNA
More news about: BillionToOne
Oct 10, 2025, 01:00 ET AECOM uppmärksammat vid FIDIC Global Infrastructure Awards för sitt arbete med Norrbotniabanan
dess genomförande. Vi är glada och stolta över att vår entusiasm för innovation, hållbarhet och globalt samarbete – principer som alla ingår i AECOM:s DNA – har uppmärksammats." Om AECOM AECOM är en global infrastrukturledare som
More news about: AECOM Nordic AB
Oct 09, 2025, 13:42 ET HUBLOT 與 DANIEL ARSHAM 攜手推出 MP-17 ARSHAM SPLASH 腕錶：藝術鐘錶工藝的流暢演變
融合的概念，無所不在，也是每個系列的指導原則。Big Bang 腕錶重塑時間的幾何形狀、Classic Fusion 腕錶平衡大膽與克制、Exceptional 腕錶則突破期望，創造前所未有的鐘錶作品。Hublot 革新傳統的創新方式，轉化 Hublot 品牌的 DNA 至 Unico、Meca-10 和陀飛輪自產機芯中，並為融合的藝術增添另一層意義。 煉金術已植根於 Hublot 之中，而不僅限於 La Manufacture。魔術可於足球場上進行，並與重大賽事（歐洲聯賽冠軍盃和歐洲國家盃™）建立合作關係。有時，它出現於音樂會、籃球比賽、藝術表演或與
More news about: Hublot SA
Oct 09, 2025, 10:05 ET Volta Labs führt automatisierten Twist-Hybridisierungs-Workflow auf Callisto ein
Twist Standard Hybridization v2 Kit – Vorteile Dank seiner Siliziumplattform und der Fähigkeit, DNA in großem Maßstab zu synthetisieren, ist Twist in der Lage, NGS-Tools mit hoher Einheitlichkeit zu entwickeln. Das Standard Hybridization v2-Kit von
More news about: Volta Labs Inc.
Oct 09, 2025, 10:00 ET Volta Labs Launches Automated Twist Hybridization Capture Workflow on Callisto
Twist Standard Hybridization v2 Kit Benefits Leveraging its silicon platform and ability to synthesize DNA at scale, Twist is able to develop NGS tools with high uniformity. Twist's Standard Hybridization v2 Kit provides researchers with uniform coverage and
More news about: Volta Labs Inc.
Oct 09, 2025, 09:47 ET Siemens and Ducati extend partnership to advance innovation in MotoGP
expression of refined engineering with a constant attention to the highest standards of quality. The Italian motorcycle manufacturer has racing in its DNA and competes with official teams in the MotoGP and WorldSBK Championships, where it tackles every race determined to continuously improve its performance
More news about: Siemens Industry Software
Oct 09, 2025, 09:30 ET FIRST CANCER PATIENT SCREENED USING ELEPHAS LIVE PLATFORM AT inDNA LIFE SCIENCES in INDIA
customized panel of DNA based Precision diagnostic and prognostic solutions which are accurate, reliable and affordable to patients and clinically relevant for doctors. inDNA is the first DNA based clinic and a molecular platform innovated to offer customized solutions for identification of DNA based changes
More news about: Elephas
Oct 09, 2025, 09:30 ET 위블로와 다니엘 아샴, MP-17 아샴 스플래시 공개 : 진화하는 예술적 오롤로지
세기를 대표하는 워치로 자리 잡았습니다. 위블로의 컬렉션 전반에는 퓨전의 개념이 깊이 스며들어 있습니다. 빅뱅 타임피스는 기존의 틀을 깨고 시간을 재해석하며, 클래식 퓨전은 대담함과 절제미를 조화롭게 담아내고, 익셉셔널 타임피스는 기대를 뛰어넘는 전에 없던 특별한 오브제를 선보입니다. 위블로의 DNA 는 유니코와 MECA-10, 투르비용 등 인하우스 무브먼트에서 빛을 발하는데, 이는 The Art of Fusion에 또 다른 의미를 더합니다. 위블로는 더 이상 기존의 방식이나 정형화된 규칙에 얽매이지 않으며, 모든 것이 새로운 해석과 도전을 통해 변화할 수 있다는 철학을 바탕으로 끊임없는 혁신을 이어가고 있습니다.
More news about: Hublot SA
Oct 09, 2025, 09:30 ET HUBLOT AND DANIEL ARSHAM UNVEIL THE MP-17 ARSHAM SPLASH : A FLUID EVOLUTION OF ARTISTIC HOROLOGY
Exceptional Timepieces overwrite expectations to create unprecedented horological objects. With its disruptive approach of challenging convention, Hublot's DNA is transcribed in the Unico, Meca-10 and tourbillon in-house movements, to add another tier of meaning to the Art of Fusion. Alchemy
More news about: Hublot SA
Oct 09, 2025, 09:30 ET HUBLOT AND DANIEL ARSHAM UNVEIL THE MP-17 ARSHAM SPLASH : A FLUID EVOLUTION OF ARTISTIC HOROLOGY
Exceptional Timepieces overwrite expectations to create unprecedented horological objects. With its disruptive approach of challenging convention, Hublot's DNA is transcribed in the Unico, Meca-10 and tourbillon in-house movements, to add another tier of meaning to the Art of Fusion. Alchemy
More news about: Hublot SA
Oct 09, 2025, 09:30 ET HUBLOT E DANIEL ARSHAM APRESENTAM O MP-17 ARSHAM SPLASH: UMA EVOLUÇÃO FLUIDA DA RELOJOARIA ARTÍSTICA
Exceptional Timepieces superam todas as expectativas com criações relojoeiras sem precedentes. Com sua disruptiva abordagem de desafiar as convenções, o DNA da Hublot é traduzido nos movimentos Unico, Meca-10 e Turbilhão que ela mesma desenvolveu internamente, adicionando mais uma camada de significado à
More news about: Hublot SA
Oct 09, 2025, 09:30 ET HUBLOT UND DANIEL ARSHAM PRÄSENTIEREN DIE MP-17 ARSHAM SPLASH: DIE JÜNGSTE EVOLUTION EINER FLUIDEN, KÜNSTLERISCHEN HAUTE HORLOGERIE
schaffen. Auch die in der eigenen Manufaktur entwickelten und produzierten Uhrwerke – Unico, Meca-10 und Tourbillonkaliber – tragen die rebellische DNA in sich, die Hublot dazu antreibt, die Konventionen ein ums andere Mal herauszufordern. Damit fügen sie der Kunst der Fusion eine weitere Bedeutungsebene
More news about: Hublot SA
Oct 09, 2025, 09:00 ET Syntax DnA³ Unites AI, Automation, and Analytics to Drive Smarter, Faster Enterprises
launch of Syntax DnA³, its Digital Innovation Center of Excellence that unites AI, automation, and analytics to help organizations unlock their data's full value and achieve faster, smarter business transformation. Built on Syntax's innovation portfolio, services, and industry expertise, DnA³ creates a trusted
More news about: Syntax
Oct 09, 2025, 08:00 ET Gap Inc. Sets Out to Reimagine Retail Powered by Google Cloud's AI
of every employee, we are freeing Gap Inc. teams to focus on creativity, culture, and customer connection while keeping the company's human-centered DNA at the core of innovation," Gerjets added. With AI strengthening its platform, Gap Inc. and Google Cloud are driving innovation,
More news about: Gap Inc.